Beltrán SSL, Martínez-Domínguez R, Enríquez-Gallegos M, Santos-Preciado JI

Language: Spanish
References: 20
Page: 91-96
PDF size: 282.76 Kb.

ABSTRACT

Background. We undertook this study to describe the clinical experience in diagnosis and treatment of visceral leishmaniasis in patients ‹15 years of age who were treated from 1990-2010 in the Hospital General Dr. Rafael Pascacio Gamboa of Tuxtla Gutiérrez, Chiapas.
Methods. This was a retrospective descriptive study. We reviewed the clinical files and epidemiological reports from the Department of Pediatrics of the Hospital General Dr. Rafael Pascacio Gamboa of Tuxtla Gutiérrez, Chiapas. All patients with a diagnosis of visceral leishmaniasis confirmed by serology, indirect immunofluorescence and the presence of amastigotes in the bone marrow aspirate were included. Epidemiological and clinical data were collected.
Results. From 1990-2010, 72 children with the diagnosis of visceral leishmaniasis were reported. Nine cases were discarded because necessary data for the analysis were not collected. Sixty three subjects who were analyzed were between 2 months and 13 years of age; 56 (88%) were ‹5 years of age. Female:male ratio was 1:1.2. Fever was present in 100% of the cases, splenomegaly in 97%, hepatomegaly in 87% and pancytopenia in 95%. Serology for leishmania by indirect immunofluorescence was ›1:32, positive in 98% of cases. The presence of amastigotes was found in 79% of the bone marrow aspirates. Leishmania chagasi was identified in culture medium 3N (Nicolle-Novy-McNeal) in five children; 75% of the children presented malnutrition.
Conclusions. In the state of Chiapas, diagnosis of visceral leishmaniasis should be considered in patients with fever, hepatosplenomegaly, and pancytopenia. The search for the parasite should be begun early to avoid clinical deterioration and pain, which leads to malnutrition and puts patients at risk of dying.

REFERENCES

1. World Health Organization. Leishmaniasis. Magnitude of the problem. Geneva. Disponible en: http://www.who.int/leishmaniasis/burden/magnitude/burden.

2. Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol 2006;22:552-557.

3. Boelaert M, Meheus F, Robays J, Lutumba P. Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis. Ann Trop Med Parasitol 2010;104:535-542.

4. Baez-Villaseñor J, Ruiloba J, Rojas LE. Presentación de un caso de Kala-azar en México. Rev Inv Clin 1952;4:57-58.

5. Aguirre A, Biagi F, Hernandez-Nieto A. Segundo caso autóctono de Kala-azar en México. Bol Med Hosp Infant Mex 1963;20:317-333.

6. Dorantes-Mesa S. Cinco casos de Kala-azar colectados en México. Bol Med Hosp Infant Mex 1988;45:546-551.

7. Velasco-Castrejón O, Guzmán-Bracho C, Rivas-Sánchez B, Aguilar-Torrentera F. Las leishmaniasis con especial referencia a México. Colección de Cuadernos Técnicos, InDRE, SSA. México D.F.; 1994.

8. Trejo-Pérez JA, Miranda-Novales M, Solórzano-Santos F, Cabrera-Muñoz L, Díaz-Ponce H. Kala-azar en México: informe de dos casos. Bol Med Hosp Infant Mex 1993;50:662-665.

9. SSA, Instituto de Salud del Estado de Chiapas, Dirección de Servicios de Salud, Depto. De Prevención y Control de Enfermedades Trasmitidas por Vector. Manual para la Vigilancia Epidemiológica de la Leishmaniasis. México; 1999.

10. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004;27:305-318.

11. Bueso-Engelhardt A, Ortega-Iglesias JC, Lopez-Aguilar A, Lanza-Fernández TO, de León-Lozano JC. Leishmaniasis visceral en Honduras. Estudio de 54 casos en un hospital infantil de referencia. Bol Med Hosp Infant Mex 1994;51:15-21.

12. Prieto-Tato LM, La Orden-Izquierdo E, Guillén-Martín S, Salcedo-Lobato E, García-Esteban C, García-Bermejo I, et al. Diagnóstico y tratamiento de la leishmaniasis visceral infantil. An Pediatr (Barc) 2010;72:347-351.

13. Valcárcel Y, Bastero R, Anegón M, González S, Gil A. Epidemiología de los ingresos hospitalarios por leishmaniasis en España (1999-2003). Enferm Infecc Microbiol Clin 2008;26:278-281.

14. Maltezou HC, Siafas C, Mavrikou M, Spyridis P, Stavrinadis C, Karpathios T, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis 2000;31:1139-1143.

15. Cascio A, Colomba C, Antinori S, Orobello M, Paterson D, Titone L. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. Eur J Clin Microbiol Infect Dis 2002;21:277-282.

16. Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PloS Negl Trop Dis 2008;2:e313.

17. Sampaio MJA, Cavalcanti NV, Alves JB, Fernandez Filho MJ, Correia JB. Risk factors for death in children with visceral leishmaniasis. PloS Negl Trop Dis 2010;4:e877.

18. Salomao F, Tavares J, D’Olveira JrA, Paraná R. Alteraciones hepáticas en la leishmaniasis visceral (Kala-azar) en niños: revisión sistemática de la literatura. Acta Gastroenterol Latinoam 2007;37:150-157.

19. Paredes R, Munoz J, Diaz I, Domingo P, Gurgui M, Clotet B. Leishmaniasis in HIV infection. J Postgrad Med 2003;49:39-49.

20. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008;21:334-359.